Clinical Trial Update: Intravenous Continuous LMWH Seems to be Safe Alternative to UFH in VV ECMO Patients

View source ↗

Summary

A completed clinical trial indicates that intravenous continuous low molecular weight heparin may be a safe alternative to unfractionated heparin in patients on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome
• Respiratory Failure

Drugs mentioned

• Low molecular weight heparin (LMWH) (low molecular weight heparin)

Snippet

Sponsor: University Hospital, Motol | Conditions: Refractory Respiratory Failure | Status: COMPLETED